308 related articles for article (PubMed ID: 21304271)
21. 7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.
Pauwels PJ; Dumontet C; Reichert JM; Beck A; Goetsch L; Corvaia N; Klein C; Coiffier B; Teicher B
MAbs; 2012; 4(4):434-44. PubMed ID: 22684281
[TBL] [Abstract][Full Text] [Related]
22. 7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.
Lugovskoy AA; Reichert JM; Beck A
MAbs; 2012; 4(2):134-52. PubMed ID: 22453093
[TBL] [Abstract][Full Text] [Related]
23. Phage display derived therapeutic antibodies.
Thie H; Meyer T; Schirrmann T; Hust M; Dübel S
Curr Pharm Biotechnol; 2008 Dec; 9(6):439-46. PubMed ID: 19075684
[TBL] [Abstract][Full Text] [Related]
24. Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody Society.
Zhang H; Deng M; Pei F; Wang S; Ho M
Antib Ther; 2019 Oct; 2(4):99-107. PubMed ID: 31942535
[TBL] [Abstract][Full Text] [Related]
25. 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.
Ho M; Royston I; Beck A
MAbs; 2012; 4(5):562-70. PubMed ID: 22864478
[TBL] [Abstract][Full Text] [Related]
26. [Next Generation Antibody Therapeutics Using Bispecific Antibody Technology].
Igawa T
Yakugaku Zasshi; 2017; 137(7):831-836. PubMed ID: 28674296
[TBL] [Abstract][Full Text] [Related]
27. Toward aggregation-resistant antibodies by design.
Lee CC; Perchiacca JM; Tessier PM
Trends Biotechnol; 2013 Nov; 31(11):612-20. PubMed ID: 23932102
[TBL] [Abstract][Full Text] [Related]
28. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
29. PepTalk--CHI's Ninth Annual Meeting--Engineering Protein & Peptide Therapeutics: Peptides.
Craik D
IDrugs; 2010 Mar; 13(3):156-8. PubMed ID: 20191429
[TBL] [Abstract][Full Text] [Related]
30. Engineering antibodies for cancer therapy.
Boder ET; Jiang W
Annu Rev Chem Biomol Eng; 2011; 2():53-75. PubMed ID: 22432610
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody therapeutics: history and future.
Buss NA; Henderson SJ; McFarlane M; Shenton JM; de Haan L
Curr Opin Pharmacol; 2012 Oct; 12(5):615-22. PubMed ID: 22920732
[TBL] [Abstract][Full Text] [Related]
32. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
[TBL] [Abstract][Full Text] [Related]
33. Historical development of monoclonal antibody therapeutics.
Nissim A; Chernajovsky Y
Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
[TBL] [Abstract][Full Text] [Related]
34. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
35. Engineering antibody therapeutics.
Chiu ML; Gilliland GL
Curr Opin Struct Biol; 2016 Jun; 38():163-73. PubMed ID: 27525816
[TBL] [Abstract][Full Text] [Related]
36. American Society of Clinical Oncology 41st annual meeting.
Dillman RO
Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
[TBL] [Abstract][Full Text] [Related]
37. Stability engineering of the human antibody repertoire.
Rouet R; Lowe D; Christ D
FEBS Lett; 2014 Jan; 588(2):269-77. PubMed ID: 24291820
[TBL] [Abstract][Full Text] [Related]
38. Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, Germany.
Reichert JM
MAbs; 2011; 3(3):223-40. PubMed ID: 21487235
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to watch in 2019.
Kaplon H; Reichert JM
MAbs; 2019; 11(2):219-238. PubMed ID: 30516432
[TBL] [Abstract][Full Text] [Related]
40. Recombinant polyclonal antibodies: the next generation of antibody therapeutics?
Haurum JS
Drug Discov Today; 2006 Jul; 11(13-14):655-60. PubMed ID: 16793535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
